Literature DB >> 9952154

Nitrous oxide produces antinociceptive response via alpha2B and/or alpha2C adrenoceptor subtypes in mice.

T Z Guo1, M F Davies, W S Kingery, A J Patterson, L E Limbird, M Maze.   

Abstract

BACKGROUND: Opiate receptors in the periaqueductal gray region and alpha2 adrenoceptors in the spinal cord of the rat mediate the antinociceptive properties of nitrous oxide (N2O). The availability of genetically altered mice facilitates the detection of the precise protein species involved in the transduction pathway. In this study, the authors establish the similarity between rats and mice in the antinociceptive action of N2O and investigate which alpha2 adrenoceptor subtypes mediate this response.
METHODS: After obtaining institutional approval, antinociceptive dose-response and time-course to N2O was measured in wild-type and transgenic mice (D79N), with a nonfunctional alpha2A adrenoceptor using tail-flick latency. The antinociceptive effect of N2O was tested after pretreatment systemically with yohimbine (nonselective alpha2 antagonist), naloxone (opiate antagonist), L659,066 (peripheral alpha2-antagonist) and prazosin (alpha2B- and alpha2C-selective antagonist). The tail-flick latency to dexmedetomidine (D-med), a nonselective alpha2 agonist, was tested in wild-type and transgenic mice.
RESULTS: N2O produced antinociception in both D79N transgenic and wild-type litter mates, although the response was less pronounced in the transgenic mice. Antinociception from N2O decreased over time with continuing exposure, and the decrement was more pronounced in the transgenic mice. The antinociceptive response could be dose dependently antagonized by opiate receptor and selective alpha2B-/alpha2C-receptor antagonists but not by a central nervous system-impermeant alpha2 antagonist (L659,066). Whereas dexmedetomidine exhibited no antinociceptive response in the D79N mice, the robust antinociceptive response in the wild-type litter mates could not be blocked by a selective alpha2B-/alpha2C-receptor antagonist.
CONCLUSION: These data confirm that the antinociceptive response to an exogenous alpha2-agonist is mediated by an alpha2A adrenoceptor and that there appears to be a role for the alpha2B- or alpha2C-adrenoceptor subtypes, or both, in the analgesic response to N2O.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952154     DOI: 10.1097/00000542-199902000-00022

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions.

Authors:  K Gyires; Z S Zádori; N Shujaa; M Al-Khrasani; B Pap; M M Mózes; P Mátyus
Journal:  Inflammopharmacology       Date:  2009-06-13       Impact factor: 4.473

Review 2.  Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts.

Authors:  Peter Nagele; Charles F Zorumski; Charles Conway
Journal:  J Clin Psychopharmacol       Date:  2018-04       Impact factor: 3.153

Review 3.  Advances in understanding the actions of nitrous oxide.

Authors:  Dimitris E Emmanouil; Raymond M Quock
Journal:  Anesth Prog       Date:  2007

4.  Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.

Authors:  S Sawamura; W S Kingery; M F Davies; G S Agashe; J D Clark; B K Kobilka; T Hashimoto; M Maze
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

Review 5.  Neurobiology of nitrous oxide-induced antinociceptive effects.

Authors:  Masahiko Fujinaga; Mervyn Maze
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

Review 6.  [Nitrous oxide. Sense or nonsense for today's anaesthesia].

Authors:  M E Schönherr; M W Hollmann; B Graf
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

Review 7.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

8.  The effect of nitrous oxide on the minimum alveolar concentration (MAC) and MAC derivatives of isoflurane in dogs.

Authors:  Debra A Voulgaris; Christine M Egger; M Reza Seddighi; Barton W Rohrbach; Lydia C Love; Thomas J Doherty
Journal:  Can J Vet Res       Date:  2013-04       Impact factor: 1.310

9.  Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome.

Authors:  Tzuping Wei; Ilya Sabsovich; Tian-Zhi Guo; Xiaoyou Shi; Rong Zhao; Wenwu Li; Christian Geis; Claudia Sommer; Wade S Kingery; David J Clark
Journal:  Eur J Pain       Date:  2008-06-12       Impact factor: 3.931

10.  MAC-sparing effect of nitrous oxide in sevoflurane anesthetized sheep and its reversal with systemic atipamezole administration.

Authors:  Lauren Duffee; Nicolò Columbano; Antonio Scanu; Valentino Melosu; Giovanni Mario Careddu; Giovanni Sotgiu; Bernd Driessen
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.